<DOC>
	<DOCNO>NCT02749994</DOCNO>
	<brief_summary>A phase Ⅲ , multi-center , randomize , double-blinded , active comparator , factorial design clinical trial compare efficacy safety combination therapy ezetimibe rosuvastatin versus monotherapy rosuvastatin hypercholesterolemia patient .</brief_summary>
	<brief_title>A Clinical Trial Compare Efficacy Safety Combination Therapy Ezetimibe Rosuvastatin Versus Monotherapy Rosuvastatin Hypercholesterolemia Patients ( I-ROSETTE Study )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . 19 ~ 79 year old 2 . Patients confirm hypercholesterolemia . 3 . Patients require drug therapy accord NCEP ATP ( National Cholesterol Education Program Adult Treatment Panel ) III Guideline Visit2 . 4 . Patients Triglyceride &lt; 400 Visit 2 . 5 . Patients washout period 4 week drug affect lipid profile . ( Patients lipid regulator washout period six week ) 6 . Patients agree participate trial 1 . Patients history myopathy rhabdomyolysis statin treatment hypersensitivity statin HMG CoA ( 3hydroxy3methylglutarylcoenzyme ) reductase inhibitor ) ezetimibe . 2 . A heavy alcohol consumer . ( alcohol &gt; 25 units/week ) 3 . Patients severe renal disease . ( creatinine ≥ 2.0 mg/dL ) 4 . Patients active liver disease AST ( aspartate transaminase ) ALT ( alanine transaminase ) &gt; 2 time upper limit normal range . 5 . Patients CPK ( creatine phosphokinase ) &gt; 2 x upper limit normal range . 6 . Patients endocrine metabolic disease know affect serum phospholipid lipoprotein . 7 . Patients HIV ( human immunodeficiency virus positive . 8 . Patients acute arteriopathy . 9 . Patients uncontrolled hypertension . 10 . Patients hereditary problem galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption . 11 . Patients drug absorption disorder gastrointestinal surgery gastrointestinal disorder . 12 . Patients tumor . 13 . Patients hormonal therapy . 14 . Pregnancy breastfeed patient n't agree use adequate contraception . 15 . Patients judge unsuitable participate study investigator . 16 . Patients take clinical trial drug within 30 day time visit screening .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>